Ryan T. Sullivan is CLO & VP at Anacor Pharmaceuticals, Inc. (ANAC). They have made 3 open-market trades across 2 companies since 2013, most recently 2020-11-13.
CIK 0001411158
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 3 sales. Too few scored purchases to measure a record yet.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ICPT | SELL | 2019-11-19 | 2019-11-19 | $85.00 | $1.0M | +31.7% | +39.0% | +13.6% |
| ICPT | SELL · 10b5-1 | 2019-11-13 | 2019-11-15 | $85.00 | $43K | +33.4% | +44.4% | +15.7% |
| ANAC | SELL | 2016-04-29 | 2016-04-29 | $66.33 | $415K | +3.4% | +56.7% | +56.5% |
| ANAC | SELL | 2016-01-04 | 2016-01-05 | $111.78 | $164K | -16.7% | -30.2% | -45.4% |
| ANAC | SELL · 10b5-1 | 2015-12-10 | 2015-12-11 | $110.41 | $1.1M | -19.4% | -19.7% | -46.3% |
| ANAC | SELL · 10b5-1 | 2015-04-29 | 2015-05-01 | $53.61 | $168K | -19.4% | +2.3% | +2.3% |
| WCRX | SELL · 10b5-1 | 2013-07-01 | 2013-07-02 | $19.88 | $3K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.